Abstract
For the diagnosis of CML and for monitoring of treatment response the detection of the t(9;22)(q34;q11) or the BCR-ABL rearrangement is necessary. Chromosome banding analysis (CA) is still the gold standard but other techniques like Southern blot, fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) are available. We analyzed 350 CML patients at different stages of disease in parallel with CA, interphase-FISH (IP-FISH), hypermetaphase-FISH (HM-FISH) and RT-PCR. In 20 cases with no Ph+ metaphases in CA, HM-FISH detected 0.2 to 10% BCR-ABL+metaphases. After IP-FISH 107 samples were judged as negative. However, in 17 of these samples HM-FISH detected BCR-ABL+ metaphases (0.3–11%), and in eight cases CA detected Ph+ metaphases (2.5–25%). A comparison of IP-FISH performed on uncultivated cells vs cells cultivated for 48 h in 70 cases revealed a higher proportion of BCR-ABL+ cells in the cultivated samples. If nested PCR was negative, all other methods were negative in all cases too. In addition, 94 cases were evaluated using real-time PCR (LightCycler technology). The BCR-ABL/cABL ratio measured showed a high correlation with all other methods. Interestingly, a wide range in the BCR-ABL/ABL ratio was observed especially in patients who showed 100% Ph-positive metaphases in CA. In conclusion, CA, IP-FISH, HM-FISH and real-time PCR give reliable results but differences due to measurement of different target structures have to be kept in mind when using these data for definition of remission status.
Similar content being viewed by others
References
Rowley JD . A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature 1973 243: 290–293
Davis RL, Konopka JB, Witte ON . Activation of the c-abl oncogene by viral transduction generates altered c-abl proteins with similar in vitro kinase properties Mol Cell Biol 1985 5: 204–213
Daley GQ, Van Etten RA, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome Science 1990 247: 824–830
Ganesan TS, Rassool R, Guo A-P, Th'ng KH, Dowding C, Hibbin JA, Young BD, White H, Kumaran TO, Galton DAG, Goldman JM . Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia Blood 1986 68: 957–960
Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D . Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization Science 1990 250: 559–562
Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP . Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro Proc Natl Acad Sci USA 1988 85: 5698–5702
Reiter A, Skladny H, Hochhaus A, Seifarth W, Heimpel H, Bartram CR, Cross NCP, Hehlmann R . Molecular response of CML patients treated with interferon-a monitored by quantitative Southern blot analysis Br J Haematol 1997 97: 86–93
Hochhaus A, Weisser A, La Rosée P, Emig M, Müller MC, Saussele S, Reiter A, Kuhn C, Berger U, Hehlmann R, Cross NCP . Detection and quantification of residual disease in chronic myelogenous leukemia Leukemia 2000 14: 998–1005
Nanjangud G, Kadam PR, Saikia T, Bhisey AN, Kumar A, Gopal R, Chopra H, Nair CN, Advani SH . Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis Leuk Res 1994 18: 385–392
Mitelman F . The cytogenetic scenario of chronic myeloid leukemia Leuk Lymphoma 1993 11: 11–15
Cross NC . Minimal residual disease in chronic myeloid leukaemia Hematol Cell Ther 1998 40: 224–228
Seong DC, Kantarjian HM, Ro JY, Talpaz M, Xu J, Robinson JR, Deisseroth AB, Champlin RE, Siciliano MJ . Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment Blood 1995 86: 2343–2349
Lion T, Izraeli S, Henn T, Gaiger A, Mor W, Gadner H . Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction Leukemia 1992 6: 495–499
Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross NC, Hochhaus A . Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR Leukemia 1999 13: 1825–1832
Preudhomme C, Revillion F, Merlat A, Hornez L, Roumier C, Duflos Grardel N, Jouet JP, Cosson A, Peyrat JP, Fenaux P . Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR assay Leukemia 1999 13: 957–964
Fonatsch C, Schaadt M, Kirchner H, Diehl V . A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines Int J Cancer 1980 26: 749–756
ISCN 1995 In: Mitelman F (ed.). Guidelines for Cancer Cytogenetics, Supplement to: An International System for HumanCytogenetic Nomenclature S Karger: Basel 1995
Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M . Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service Ann Intern Med 1995 122: 254–261
Maurer J, Janssen JWG, Thiel E, van Denderen J, Ludwig W-D, Aydemir Ü, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR . Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by polymerase chain reaction Lancet 1991 337: 1055–1058
Seong CM, Giralt S, Kantarjian H, Xu J, Swantkowski J, Hayes K, Glassman AB, Khouri I, Korbling M, Thall P, Siciliano MJ, Champlin RE . Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia J Clin Oncol 2000 18: 1831–1836
Wilkens L, Varga S, Werner M, Nolte M, v Wasielewski R, Georgii A . Short-term culturing influences the number of bcr/abl-fused cells detected by fluorescence in situ hybridisation in bone marrow aspirates of CML patients Pathobiology 1999 67: 163–168
Cuneo A, Bigoni R, Emmanuel B, Smit E, Rigolin GM, Roberti MG, Bardi A, Piva N, Scapoli G, Castoldi G, Van Den Berghe H, Hagemeijer A . Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis Leukemia 1998 12: 1718–1723
Buno I, Wyatt WA, Zinsmeister AR, Dietz Band J, Silver RT, Dewald GW . A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia Blood 1998 92: 2315–2321
Muhlmann J, Thaler J, Hilbe W, Bechter O, Erdel M, Utermann G, Duba HC . Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment Genes Chromosomes Cancer 1998 21: 90–100
Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R, Avet Loiseau H . Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia J Clin Oncol 2000 18: 1533–1538
Sinclair PB, Green AR, Grace C, Nacheva EP . Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system Blood 1997 90: 1395–1402
Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM, Spurbeck JL, Silver RT . Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia Blood 1998 91: 3357–3365
Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P . Polymerase chain-reaction detection for the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implication in 346 patients Blood 1995 85: 2632–2640
Acknowledgements
This study was supported by grants from the German José Carreras-Foundation to TH and AH and is part of the Kompetenznetz ‘Akute und chronische Leukämien’ supported by the German Bundesminister für Bildung und Forschung.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schoch, C., Schnittger, S., Bursch, S. et al. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia 16, 53–59 (2002). https://doi.org/10.1038/sj.leu.2402329
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402329
- Springer Nature Limited
Keywords
This article is cited by
-
Risk prediction in MDS: independent validation of the IPSS-M—ready for routine?
Leukemia (2023)
-
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis
Leukemia (2022)
-
AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics
Leukemia (2022)
-
Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia
BMC Cancer (2021)
-
First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder
Scientific Reports (2021)